In line with this postulate are the findings of Carter et al. (2012) who reported a patient with a germline SMARCB1 frameshift mutation in exon 3 and several schwannomas which were classified as ‘neuroblastoma-like’ (Supp. Here, SMARCB1 is linked to schwannoma.